Oncology

Immunotherapy Resistance Mechanisms

Investigation of molecular pathways enabling tumors to evade checkpoint inhibitor therapies and strategies to overcome adaptive resistance.

RESEARCH GAP FRONTIERS

Liquid Biopsy Biomarker Discovery

Development of circulating tumor DNA and protein markers for early cancer detection and real-time therapeutic monitoring.

RESEARCH GAP FRONTIERS

CAR-T Cell Engineering Optimization

Enhancement of chimeric antigen receptor T-cell design for improved tumor targeting and reduced off-target toxicity.

RESEARCH GAP FRONTIERS

Tumor Microenvironment Immunosuppression

Characterization of stromal and immune cell interactions that establish immunosuppressive niches within solid tumors.

RESEARCH GAP FRONTIERS

Precision Oncology Genomics Integration

Multi-omics approaches combining genomic, transcriptomic, and proteomic data for personalized cancer treatment selection.

RESEARCH GAP FRONTIERS

Metastatic Niche Colonization Biology

Study of organ-specific stromal factors and pre-metastatic niche formation that facilitate distant tumor seeding.

RESEARCH GAP FRONTIERS

Epigenetic Reprogramming Cancer Plasticity

Analysis of histone modifications and DNA methylation driving cellular dedifferentiation and therapeutic adaptation.

RESEARCH GAP FRONTIERS

Synthetic Lethality Drug Discovery

Identification of genetic vulnerabilities in cancer cells for development of novel targeted combination therapies.

RESEARCH GAP FRONTIERS

RNA Therapeutics Cancer Treatment

Design and clinical translation of siRNA, miRNA, and circular RNA-based therapeutics targeting oncogenic pathways.

Tumor Evolution Clonal Dynamics

Mathematical modeling of cancer subclonal heterogeneity and evolutionary trajectories predicting treatment response.

Neutrophil Extracellular Traps Oncology

Investigation of NET-mediated immunosuppression and thrombosis in cancer progression and metastasis.

Spatial Transcriptomics Tumor Architecture

High-resolution mapping of gene expression patterns preserving tissue architecture across cancer specimens.

CRISPR Cancer Gene Therapy

Development of CRISPR-Cas9 systems for ex vivo and in vivo correction of oncogenic mutations.

Angiogenesis Inhibition Mechanism

Study of anti-VEGF resistance and alternative vascularization pathways in solid tumor progression.

Cancer Metabolism Aerobic Glycolysis

Metabolic reprogramming analysis targeting the Warburg effect and glutaminolysis for therapeutic intervention.

Artificial Intelligence Drug Screening

Machine learning models predicting drug sensitivity from tumor genomic and phenotypic features.

Cancer Stem Cell Maintenance

Characterization of self-renewal mechanisms and differentiation blockade in cancer-initiating cell populations.

Immunogenic Cell Death Induction

Investigation of chemotherapy, radiation, and targeted agents triggering immunostimulatory tumor cell death.

Brain Tumor Blood Barrier Penetration

Development of nanoparticle and antibody technologies overcoming blood-brain barrier for CNS malignancies.

Tumor Associated Fibroblast Activation

Molecular mechanisms of cancer-associated fibroblast differentiation and desmoplastic stroma contribution to progression.

Organ-Specific Cancer Tropism

Analysis of tissue-specific factors determining cancer cell extravasation and colonization in different organs.

Immunological Memory Checkpoint Reinvigoration

Strategies for restoring exhausted T-cell populations through multi-target checkpoint blockade combinations.

Circulating Tumor Cell Isolation

Novel microfluidic and immunomagnetic technologies for enumeration and characterization of CTCs in blood.

Radiotherapy Immunotherapy Synergy

Mechanistic studies of radiotherapy-induced immunogenicity enhancing checkpoint inhibitor efficacy.

Tumor Hypoxia Adaptive Signaling

HIF-1 pathway mechanisms enabling metabolic reprogramming and therapeutic resistance in low-oxygen microenvironments.

Neoantigen Personalized Cancer Vaccine

Design and clinical validation of mutation-derived epitope vaccines for individualized immunotherapy.

Dormant Micrometastasis Reactivation

Mechanisms of latent cancer cell awakening and strategies to maintain metastatic quiescence.

Nanomedicine Tumor Drug Delivery

Engineering of lipid, polymeric, and metal nanoparticles for targeted delivery and accumulation in tumors.

Gut Microbiota Cancer Immunotherapy

Investigation of commensal bacteria influence on checkpoint inhibitor response and immune checkpoint function.

Hormone Receptor Signaling Plasticity

Mechanisms of estrogen and androgen receptor switching enabling endocrine therapy resistance in breast and prostate cancers.

Single-Cell RNA Sequencing Analysis

High-throughput scRNA-seq for identifying rare cell populations and cell-state transitions in heterogeneous tumors.

Tumor-Associated Macrophage Polarization

Programming of pro-tumor M2 macrophages and strategies for phenotypic repolarization toward anti-tumor activity.

DNA Repair Synthetic Vulnerability

Exploitation of BRCA deficiency and mismatch repair defects through PARP inhibitors and immunotherapy combinations.

Cancer Cell Plasticity Phenotype Switching

Epithelial-mesenchymal transition and reverse transitions governing invasiveness and therapeutic susceptibility.

Immunosuppressive Myeloid Expansion

Characterization of myeloid-derived suppressor cell differentiation and function in immune checkpoint resistance.

Extracellular Matrix Remodeling Invasion

Matrix metalloproteinase activity and integrin signaling mediating epithelial barrier disruption and metastasis.

Telomerase Immortalization Mechanisms

Telomere maintenance pathways and alternative lengthening of telomeres in unlimited cancer cell replication.

Oncolytic Virus Cancer Immunotherapy

Engineering of cancer-selective replicating viruses for direct tumor lysis and immunogenicity induction.

Metabolic Heterogeneity Tumor Microenvironment

Spatial and functional metabolic diversity across cancer, immune, and stromal cell populations.

Kinase Inhibitor Resistance Mechanisms

Secondary mutations and pathway rewiring enabling escape from targeted tyrosine kinase inhibitors.

Microfluidic Tumor Model Engineering

Organ-on-chip technologies recapitulating tumor-stromal interactions for drug screening and mechanism studies.

Regulatory T Cell Suppression Reversal

Strategies targeting FOXP3+ Treg depletion or functional inactivation to enhance anti-tumor immunity.

Proteomics Protein Phosphorylation Mapping

Mass spectrometry-based quantification of phosphoproteomic signatures predicting kinase dependency.

Cancer Associated Inflammation NF-kB

Nuclear factor kappa-B pathway activation sustaining chronic inflammation and tumor-promoting cytokines.

Antibody Engineering Bispecific Therapeutics

Design of bispecific antibodies simultaneously engaging tumor antigens and immune effector cells.

Pancreatic Cancer Desmoplasia Targeting

Strategies for disrupting dense fibrotic stroma to improve chemotherapy and immunotherapy penetration.

Liquid-Liquid Phase Separation Oncology

Investigation of biomolecular condensate formation in transcriptional regulation and oncogene clustering.

B-Cell Lymphoma Antigen Escape

Mechanisms of CD19 and CD20 antigen loss enabling CAR-T cell therapy resistance in hematologic malignancies.

Organoid Culture Patient-Derived Tumor

Three-dimensional tumor organoid generation for personalized drug testing and mechanistic discovery.

Extracellular Vesicle Biomarker Communication

Exosome and microvesicle-mediated intercellular communication in tumor progression and treatment response.

Tumor Mutational Burden Predictive Immunotherapy

Investigation of tumor mutational burden as a predictive biomarker for immunotherapy response and clinical outcome stratification.

Ferroptosis Cancer Cell Death Induction

Exploration of iron-dependent cell death pathways and ferroptosis inducers as novel cancer therapeutic targets.

Chromatin Accessibility Cancer Transcriptomics

Analysis of chromatin remodeling and open chromatin regions driving oncogenic transcriptional programs.

Pyroptosis Inflammatory Cancer Immunogenicity

Investigation of programmed inflammatory cell death mechanisms to enhance anti-tumor immune activation.

Membrane Protein Glycosylation Cancer Signaling

Study of aberrant glycosylation patterns on cancer cell surfaces and their role in immune evasion.

Tumor Vascular Normalization Therapy Strategy

Development of approaches to normalize dysfunctional tumor vasculature and improve drug delivery efficiency.

Cancer Proteogenomics Mutation Protein Validation

Integration of genomic mutations with proteomics data to identify and validate novel cancer-associated proteins.

Senescent Cancer Cell Immunological Recognition

Study of immunogenic properties of therapy-induced senescent cancer cells and their immune clearance.

Lipid Droplet Metabolism Cancer Progression

Investigation of lipid storage and mobilization mechanisms in cancer cell survival and treatment resistance.

Transcription Factor Rewiring Cancer Plasticity

Analysis of transcriptional network rewiring that enables cancer cells to adopt alternative phenotypic states.

Tumor-Infiltrating Lymphocyte Exhaustion Reversal

Development of strategies to restore function and prevent exhaustion in tumor-resident T lymphocytes.

Splicing Factor Mutations Cancer Dependency

Investigation of spliceosome dysregulation in cancer and therapeutic exploitation of splicing dependencies.

Immunological Imprinting Tissue-Resident Memory

Study of local immune memory formation in tumors and strategies to establish durable anti-cancer immunity.

Mutant p53 Gain-of-Function Oncogenesis

Characterization of oncogenic properties of mutant p53 beyond loss of tumor suppression function.

Bone Marrow Niche Cancer Metastasis Seeding

Investigation of bone marrow microenvironment factors that facilitate cancer cell homing and colonization.

Metabolic Symbiosis Tumor Immune Cells

Study of metabolic cross-talk between cancer cells and infiltrating immune populations in the tumor niche.

Autophagy Flux Cancer Drug Resistance

Analysis of autophagy pathway dynamics in mediating cancer cell survival under therapeutic stress.

Immune Checkpoint Antagonist Combination Therapy

Optimization of multi-target checkpoint inhibition strategies to overcome resistance mechanisms.

Colorectal Cancer Adenoma-Carcinoma Progression

Molecular characterization of sequential genetic events driving colorectal tumorigenesis and early intervention.

Natural Killer Cell Activation Restoration

Development of strategies to enhance natural killer cell recognition and elimination of cancer cells.

Cancer Exosome Immunomodulatory Cargo Transfer

Investigation of immunosuppressive molecules transferred via cancer-derived exosomes and functional blockade.

Squamous Cell Carcinoma Immune Landscape

Comprehensive profiling of immune infiltration patterns in squamous malignancies across anatomical sites.

Metabolic Checkpoint Inhibition Cancer Immunity

Targeting of metabolic gatekeepers to unlock anti-tumor immune responses and improve immunotherapy.

Mechanical Forces Tumor Cell Migration

Study of mechanotransduction mechanisms enabling cancer cell invasion and tissue permeability across barriers.

Lung Cancer Adenocarcinoma Subtypes Molecular

Classification and characterization of distinct molecular subtypes in lung adenocarcinoma with treatment implications.

Dendritic Cell Activation Cancer Vaccination

Engineering of dendritic cell responses for enhanced presentation and priming of anti-tumor immunity.

Mitochondrial Dysfunction Cancer Metabolic Shift

Investigation of mitochondrial defects driving metabolic reprogramming and cancer progression.

Tumor Heterogeneity Intra-lesional Spatial Mapping

High-resolution spatial analysis of genetic and phenotypic diversity within individual tumor lesions.

Breast Cancer Luminal Basal Classification

Molecular subtyping and therapeutic stratification of breast cancers based on luminal and basal properties.

Histone Deacetylase Inhibitor Epigenetic Remodeling

Mechanism of action and therapeutic optimization of histone deacetylase inhibitors in cancer treatment.

Tumor-Associated Neutrophil Protumoral Functions

Characterization of neutrophil subsets and their pro-tumoral activities in the oncogenic microenvironment.

Cancer Cell Quiescence Dormancy Regulation

Investigation of mechanisms controlling cancer cell entry into dormancy and reactivation from latency.

Melanoma BRAF Mutation Targeted Therapy

Development and optimization of BRAF inhibitor strategies with consideration of resistance mechanisms.

RNA Secondary Structure Cancer Therapeutics

Targeting of RNA secondary structures as novel druggable elements in cancer-associated transcripts.

Ovarian Cancer High-Grade Serous Subtype

Molecular profiling and therapeutic targeting of high-grade serous ovarian carcinoma specificities.

Immune Infiltration Tumor Regression Prediction

Development of biomarkers based on immune cell abundance and phenotype for therapy response prediction.

Cancer Cell-Derived Growth Factor Autocrine

Study of autocrine and paracrine growth factor signaling networks sustaining cancer proliferation.

Prostate Cancer Androgen Receptor Signaling

Investigation of androgen receptor mutations and bypass mechanisms in hormone-resistant prostate cancer.

Immunotherapy Biomarker Machine Learning Prediction

Development of machine learning models integrating multi-omics data to predict immunotherapy responses.

Lymphatic Vessel Cancer Dissemination Route

Study of lymphangiogenesis and lymphatic system involvement in cancer metastatic spread.

Metabolic Enzyme Cancer Dependency Prediction

Identification of metabolic enzymes essential for specific cancer types through functional genomics.

Gastrointestinal Stromal Tumor KIT Mutation

Analysis of KIT and PDGFRA mutations in gastrointestinal stromal tumors and treatment strategies.

Myeloid-Derived Suppressor Expansion Modulation

Strategies to reduce myeloid-derived suppressor cell differentiation and immunosuppressive functions.

Cancer Drug Efficacy Cell Line Prediction

Development of genomic signatures predicting drug sensitivity across diverse cancer cell line models.

Hepatocellular Carcinoma Viral Etiology Role

Investigation of hepatitis B and C virus contributions to hepatocellular carcinoma development.

DNA Methylation Cancer Biomarker Panel Development

Creation of DNA methylation signatures for cancer detection, classification, and prognosis assessment.

Endothelial Cell Dysfunction Tumor Barrier

Investigation of endothelial barrier dysfunction in tumors facilitating immune cell infiltration.

Head Neck Cancer HPV Integration Oncogenesis

Study of human papillomavirus integration patterns and oncogenic mechanisms in head and neck cancers.

Immune Reconstitution Inflammatory Syndrome Cancer

Analysis of immune reactivation flares during immunotherapy and management strategies in cancer patients.

Tissue-Specific Cancer Driver Gene Identification

Discovery of tissue-specific driver mutations and therapeutic targets across diverse cancer types.

Tumor Suppressor Gene Inactivation Pathways

Investigation of molecular mechanisms underlying loss of p53, RB, and PTEN function in cancer initiation and progression.

Oncogenic Viral Integration Chromosomal Instability

Study of how HPV and HBV integration events drive genomic rearrangements and malignant transformation in epithelial tissues.

Ferroptosis Iron Metabolism Cancer Therapy

Exploration of iron-dependent cell death pathways as therapeutic targets for chemotherapy-resistant and immunotherapy-refractory tumors.

Notch Signaling Stem Cell Differentiation

Examination of Notch pathway roles in cancer stem cell maintenance and potential therapeutic targeting strategies.

Wnt Beta-Catenin Pathway Colorectal Tumorigenesis

Analysis of aberrant Wnt signaling mechanisms in APC-mutant colorectal cancer development and therapeutic intervention.

Hedgehog Signaling Medulloblastoma Development

Investigation of sonic hedgehog pathway dysregulation in pediatric brain tumor formation and subtype stratification.

KRAS Allele-Specific Mutation Therapy Resistance

Study of how different KRAS mutations confer distinct therapeutic sensitivities and mechanisms of drug resistance.

MYC Oncogenic Addiction Synthetic Lethality

Research on MYC-driven cancers'' dependence on specific pathways for identifying novel therapeutic vulnerabilities.

TP53 Mutation Germline Cancer Predisposition

Investigation of Li-Fraumeni syndrome pathogenesis and clinical implications of TP53 variants in hereditary cancer.

BRCA Homologous Recombination DNA Repair

Examination of BRCA1 and BRCA2 loss-of-function in breast and ovarian cancer susceptibility and PARP inhibitor response.

Mismatch Repair Lynch Syndrome Colorectal Cancer

Study of MLH1, MSH2, and MSH6 mutations in microsatellite instability-high tumors and immunotherapy outcomes.

PI3K AKT mTOR Pathway Hyperactivation

Analysis of phosphatidylinositol signaling alterations driving tumor growth and resistance to targeted inhibition.

MAPK ERK Pathway Melanoma Addiction

Investigation of BRAF and NRAS mutations in cutaneous melanoma and acquired resistance to kinase inhibitors.

NF-kB Inflammation Driven Lymphomagenesis

Exploration of constitutive NF-kB signaling in B-cell lymphomas and therapeutic targeting of pathway components.

JAK STAT Hematologic Malignancy Signaling

Study of aberrant JAK-STAT activation in myeloproliferative neoplasms and acute leukemias with therapeutic implications.

Histone Acetylation Cancer Gene Regulation

Investigation of HDAC dysregulation and histone acetyltransferase mutations in epigenetic cancer pathogenesis.

DNA Methylation CpG Island Promoter Silencing

Analysis of aberrant CpG methylation patterns inactivating tumor suppressors and implications for methyltransferase inhibition.

Chromatin Remodeling SWI SNF Complex Mutations

Study of BAF complex alterations in synovial sarcomas and other malignancies affecting chromatin accessibility.

MicroRNA Oncogenic miR-155 Expression

Investigation of microRNA dysregulation in lymphoid malignancies and potential anti-miR therapeutic approaches.

Long Non-Coding RNA Cancer Progression

Exploration of HOTAIR and other lncRNAs'' roles in metastasis, drug resistance, and therapeutic targeting.

Circular RNA Sponge Activity Oncogenesis

Study of circRNA-miRNA interactions in regulating cancer-related gene expression and their therapeutic potential.

Alternative Splicing Cancer Protein Isoforms

Analysis of aberrant pre-mRNA splicing generating oncogenic protein variants and targeting through splice modulation.

Translation Control IRES IRE Regulation

Investigation of internal ribosome entry sites enabling selective translation of oncogenes under stress conditions.

Tumor Vascularization VEGF Signaling Blockade

Study of anti-angiogenic mechanisms and resistance development to VEGF receptor inhibitors in solid tumors.

Lymphangiogenesis Metastatic Lymph Node Colonization

Examination of VEGF-C and VEGF-D-mediated lymphatic vessel formation facilitating lymph node metastasis.

Hypoxia Inducible Factor HIF Signaling

Investigation of HIF-1 and HIF-2 transcriptional programs in tumor adaptation and therapeutic vulnerability.

Glutamine Metabolism Cancer Cell Proliferation

Study of glutaminolysis dependence in transformed cells and GLS inhibitor efficacy in specific tumor types.

Lipid Metabolism Membrane Synthesis Tumors

Exploration of upregulated fatty acid synthesis and lipogenesis supporting rapid cancer cell division.

Amino Acid Auxotrophy Cancer Immunotherapy

Investigation of arginine and tryptophan depletion strategies enhancing anti-tumor immune responses.

Mitochondrial Dysfunction OXPHOS Cancer Metabolism

Study of oncogene-induced mitochondrial alterations and complex I inhibition in metabolically distinct tumors.

Autophagy Mitophagy Cancer Cell Survival

Analysis of macroautophagy and selective autophagy pathways sustaining cancer cells under nutrient stress.

Apoptosis Resistance BCL-2 Family Proteins

Investigation of anti-apoptotic BCL-2, MCL-1 overexpression and BH3 mimetic therapeutic strategies.

Senescence Bypass p16 INK4a Inactivation

Study of how cancers overcome replicative senescence through p16 loss and telomerase reactivation.

Chromosomal Instability Aneuploidy Cancer Progression

Examination of CIN mechanisms driving tumor heterogeneity and immunogenic implications of chromosomal aberrations.

Translocations Fusion Gene Sarcoma Oncogenesis

Investigation of recurrent translocations creating pathognomonic fusion proteins in soft tissue and bone malignancies.

Amplification Driver Gene Copy Number Gain

Study of HER2, EGFR, MYC amplification mechanisms and therapeutic targeting via receptor inhibitors.

Deletions Tumor Suppressor Copy Number Loss

Analysis of recurrent deletions affecting TP53, PTEN, NF1 and other tumor suppressors in specific cancers.

Immunoglobulin Heavy Chain VDJ Rearrangement

Investigation of clonal B-cell receptor rearrangements in lymphoma development and minimal residual disease detection.

T-Cell Receptor Gamma Delta Lymphoma

Study of TCR-gamma-delta clonal proliferation in cutaneous and nodal peripheral T-cell lymphomas.

Immune Checkpoint PD-1 PD-L1 Blockade

Examination of mechanisms of action and resistance to monoclonal antibodies targeting programmed death pathways.

CTLA-4 Co-Inhibition Combination Immunotherapy

Investigation of dual checkpoint inhibition enhancing anti-tumor T-cell responses in melanoma and other malignancies.

Natural Killer Cell Dysfunction Tumor Evasion

Study of NK cell exhaustion mechanisms and therapeutic strategies to restore anti-tumor NK cell functions.

Dendritic Cell Activation Antigen Presentation

Exploration of DC-based cancer vaccines and strategies to overcome tumor-induced dendritic cell dysfunction.

Tumor Infiltrating Lymphocyte Therapy Expansion

Investigation of TIL isolation and ex vivo expansion for adoptive cell transfer in solid tumors.

Bispecific T-Cell Engaging BiTE Antibodies

Study of bispecific antibodies simultaneously binding CD3 and tumor antigens for enhanced T-cell activation.

Checkpoint Ligand Expression Tumor Microenvironment

Analysis of PD-L1, PD-L2, B7-H3 expression by tumor and immune cells and predictive value for immunotherapy.

Tertiary Lymphoid Structure Formation Immunogenicity

Investigation of ectopic lymphoid aggregates within tumors as prognostic markers and therapeutic targets.

Stromal Cell Derived Factor Chemokine Axis

Study of CXCL12-CXCR4 signaling in leukemic cell homing and therapeutic blocking in hematologic malignancies.

Bone Marrow Niche Leukemia Quiescence

Examination of stromal interactions promoting minimal residual disease and chemotherapy resistance in acute leukemia.

Lymph Node Stromal Architecture Cancer Spread

Investigation of lymph node microarchitecture remodeling facilitating metastatic tumor cell colonization.

Ferroptosis Induction Cancer Cell Death

Investigation of iron-dependent cell death pathways as therapeutic targets for overcoming apoptosis-resistant cancers.

Tumor Infiltrating Lymphocyte Expansion Therapy

Development of ex vivo expansion and reinfusion strategies for endogenous tumor-reactive T cells.

Pyroptosis Immune Activation Cancer Treatment

Exploration of inflammasome-mediated pyroptotic pathways to enhance anti-tumor immune responses.

Histone Deacetylase Inhibitor Combination Strategy

Mechanistic studies of HDAC inhibitors combined with immunotherapy for epigenetic sensitization.

Glycolytic Inhibition Tumor Metabolism Reversal

Targeting Warburg effect through glycolysis inhibition to starve cancer cells of energy.

Mesenchymal Stromal Cell Cancer Interaction

Analysis of bone marrow-derived stromal cell contributions to tumor progression and therapy resistance.

Cancer Associated Adipocyte Lipid Metabolism

Investigation of adipocyte-derived lipids as nutrient sources supporting tumor growth.

Senescent Cell Immunogenicity Clearance Strategy

Harnessing senolytic drugs to eliminate therapy-induced senescent cancer cells and reduce immunosuppression.

Membranous Protein Shedding Immunotherapy Evasion

Study of cancer cell surface protein shedding mechanisms that evade immune checkpoint targeting.

Mitochondrial Dysfunction Cancer Metabolism Vulnerability

Exploitation of cancer cell mitochondrial defects to induce metabolic stress and cell death.

Spatial Immune Cell Proximity Profiling

High-resolution mapping of immune-tumor cell interactions within native tissue microenvironments.

Personalized Neoantigen Vaccine Manufacturing

Rapid patient-specific mutation-derived peptide vaccine production for therapeutic cancer immunization.

Tertiary Lymphoid Structure Formation Activation

Induction of ectopic lymphoid tissue within tumors to promote anti-tumor immune responses.

Tumor Vasculature Normalization Immunotherapy Enhancement

Strategies to normalize abnormal tumor vessels and improve immune cell infiltration.

Cancer Cell Fitness Cost Trade-off Analysis

Systems biology approach to exploiting competing metabolic and immunogenic demands on cancer cells.

Molecular Subtype Targeted Therapy Prediction

Machine learning models integrating multi-omics data to predict therapeutic response by tumor subtype.

Hypoxia Adaptive Response HIF Signaling Inhibition

Targeting hypoxia-inducible factor pathways to reverse hypoxic tumor microenvironment adaptation.

Cell-Cell Adhesion Cancer Invasion Blockade

Therapeutic targeting of adhesion molecule loss to prevent epithelial-mesenchymal transition.

Sarcoma Fusion Protein Dependency Targeting

Design of inhibitors against oncogenic fusion proteins unique to sarcoma malignancies.

Leukemia Leukemic Stem Cell Maintenance

Understanding quiescence mechanisms in leukemic stem cells resistant to standard chemotherapy.

Melanoma BRAF Mutation Acquired Resistance

Mechanisms of resistance development to BRAF inhibitors in melanoma treatment.

Ovarian Cancer Platinum Resistance Mechanism

Molecular mechanisms underlying chemotherapy resistance in platinum-treated ovarian cancers.

Prostate Cancer Androgen Independence Conversion

Pathways driving castration-resistant prostate cancer development and therapeutic intervention strategies.

Gastric Cancer Diffuse Signet Ring Cell

Unique biological properties of diffuse-type gastric adenocarcinoma with CDH1 mutations.

Colorectal Cancer Microsatellite Instability Immunology

Enhanced immunogenicity and checkpoint inhibitor response in microsatellite-unstable colorectal cancers.

Glioblastoma Tumor Treating Field Optimization

Mechanisms and optimization of alternating electric fields for glioblastoma treatment.

Mesothelioma Asbestos-Induced Carcinogenesis Biology

Investigation of chronic inflammation pathways driving asbestos-induced mesothelioma development.

Hepatocellular Carcinoma Cirrhotic Microenvironment

Interactions between hepatic cirrhosis and tumor initiation in hepatocellular carcinoma.

Cholangiocarcinoma Biliary Epithelial Transformation

Mechanisms of malignant transformation in biliary tract epithelial cells.

Renal Cell Carcinoma Hypoxia Dependency

VHL loss-driven hypoxia signaling as therapeutic vulnerability in renal cell carcinoma.

Lung Adenocarcinoma Driver Mutation Heterogeneity

Co-occurring mutations in lung adenocarcinoma affecting treatment resistance patterns.

Cervical Cancer HPV Integration Genomic Instability

Human papillomavirus integration sites and resulting chromosomal instability in cervical cancer.

Lymphoma Germinal Center B Cell Origin

Understanding germinal center-derived lymphoma pathogenesis and immune escape mechanisms.

Neuroblastoma MYCN Amplification Therapy Targeting

Therapeutic strategies against MYCN-driven high-risk neuroblastoma malignancies.

Wilms Tumor WT1 Gene Inactivation Biology

WT1 tumor suppressor function and development of targeted renal tumor therapies.

Breast Cancer Luminal Subtype Endocrine Resistance

Estrogen receptor signaling plasticity driving hormone therapy resistance in luminal cancers.

Triple Negative Breast Cancer Immunotherapy Response

Predictive biomarkers and mechanisms of checkpoint inhibitor response in TNBC.

HER2 Positive Breast Cancer Trastuzumab Resistance

Escape mechanisms from HER2-targeted therapy in breast cancer metastases.

Squamous Cell Carcinoma Immune Desert Conversion

Converting immune-excluded squamous cell carcinomas into immunogenic microenvironments.

Uveal Melanoma Monosomy Three Prognosis

Chromosome 3 loss mechanisms predicting metastatic risk in uveal melanoma.

Merkel Cell Carcinoma Polyomavirus Integration

Merkel cell polyomavirus role in carcinogenesis and therapeutic vulnerability.

Kaposi Sarcoma HHV-8 Latency Reactivation

Human herpesvirus 8 latent gene expression driving Kaposi sarcoma pathogenesis.

Thyroid Cancer Radioiodine Resistance Mechanism

Loss of radioiodine uptake and therapeutic strategies for radioiodine-refractory thyroid cancer.

Neuroendocrine Tumor Somatostatin Receptor Biology

Somatostatin receptor expression patterns guiding targeted peptide and immunotherapy approaches.

Myelin Associated Glycoprotein Cancer Antigen

MAG antigen targeting in demyelinating peripheral neuropathy-associated lymphomas.

Cancer Drug Metabolism Pharmacogenomic Prediction

Cytochrome P450 polymorphisms and metabolism predicting chemotherapy efficacy and toxicity.

Tumor Associated Thrombosis Prevention Strategy

Cancer cell-induced hypercoagulability and anticoagulation strategies in oncology.

Cancer Cachexia Myostatin Signaling Reversal

Targeting myostatin and inflammatory pathways driving cancer-related muscle wasting.

Cancer Associated Cognitive Impairment Neuroinflammation

Neuroinflammatory mechanisms underlying chemotherapy-induced cognitive dysfunction.

Long-Term Cancer Survivor Cardiotoxicity Mitigation

Prevention and management of anthracycline and HER2 inhibitor-induced cardiac damage.